Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Stem cell therapy is the use of stem cells to treat or prevent a disease or condition.
Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, and to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes, heart disease, and other conditions.
Stem cell therapy has become controversial following developments such as the ability of scientists to isolate and culture embryonic stem cells, to create stem cells using somatic cell nuclear transfer and their use of techniques to create induced pluripotent stem cells. This controversy is often related to abortion politics and to human cloning. Additionally, efforts to market treatments based on transplant of stored umbilical cord blood have been controversial.
According to authoritative organization forecast, the global Stem Cell Therapies Market is expected to reach about USD 233.7 million by 2019, registering a CAGR of approximately 41.2% during the forecast period from 2015 to 2019.
At present therapeutic applications of stem cell therapies include eye diseases, CNS diseases, metabolic diseases, CVS diseases, GIT diseases, musculoskeletal disorders, immune system diseases, wounds and injuries and others.
By geographies, due to strong government funding and increasing fast-track approval for stem cell therapeutics by the FDA, North America occupied the largest market share in 2015 and is expected to continue in the next five years, followed by Europe. The Asia Pacific region will grow at the highest CAGR from 2015 to 2019, this is because of strong product lines, increasing regulatory support through favorable government policies and increasing licensing activities in the Asia Pacific.
There are many participants in the stem cell therapies market and the major participants include Aastrom Biosciences, Inc. (U.S.), StemCells, Inc. (U.S.), Roslin Cells (UK), Mesoblast Ltd. (Australia), Regeneus Ltd (Australia), International Stem Cell Corporation (U.S.).
Request Sample 
Request Discount 
Inquire Before Buy
